Sunday, April 27, 2025
Biogen are withdrawing from the NICE appraisal for Skyclarys
Biogen. 24th April 2025, Following your request for information, I want to inform you that Biogen has withdrawn omaveloxolone from the National Institute for Health and Care Excellence (NICE) appraisal process. This follows the news of the medicine’s approval by the Medicines and Healthcare products Regulatory Agency (MHRA) on 23rd April.
